Compass Capital Management Inc. reduced its stake in shares of C.R. Bard Inc. (NYSE:BCR) by 4.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,243 shares of the company’s stock after selling 4,339 shares during the period. C.R. Bard comprises about 4.4% of Compass Capital Management Inc.’s holdings, making the stock its largest position. Compass Capital Management Inc. owned approximately 0.13% of C.R. Bard worth $22,868,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the stock. Standard Life Investments LTD bought a new stake in C.R. Bard during the second quarter worth about $241,642,000. JPMorgan Chase & Co. raised its position in shares of C.R. Bard by 353.4% in the first quarter. JPMorgan Chase & Co. now owns 667,533 shares of the company’s stock worth $135,290,000 after buying an additional 520,319 shares in the last quarter. Bank of Montreal Can acquired a new position in shares of C.R. Bard during the second quarter worth $96,292,000. Renaissance Technologies LLC raised its position in shares of C.R. Bard by 23.4% in the first quarter. Renaissance Technologies LLC now owns 1,355,300 shares of the company’s stock worth $274,679,000 after buying an additional 256,800 shares in the last quarter. Finally, BlackRock Fund Advisors raised its position in shares of C.R. Bard by 8.5% in the first quarter. BlackRock Fund Advisors now owns 1,886,656 shares of the company’s stock worth $382,369,000 after buying an additional 147,571 shares in the last quarter. Hedge funds and other institutional investors own 87.90% of the company’s stock.

Institutional Ownership by Quarter for C.R. Bard (NYSE:BCR)

C.R. Bard Inc. (NYSE:BCR) traded down 0.98% on Tuesday, reaching $221.58. The company’s stock had a trading volume of 460,550 shares. The company has a market capitalization of $16.28 billion, a PE ratio of 51.53 and a beta of 0.50. The firm has a 50-day moving average of $221.54 and a 200-day moving average of $219.74. C.R. Bard Inc. has a one year low of $172.21 and a one year high of $239.43.

C.R. Bard (NYSE:BCR) last posted its quarterly earnings results on Tuesday, July 26th. The company reported $2.54 EPS for the quarter, beating the Zacks’ consensus estimate of $2.47 by $0.07. The business had revenue of $931.50 million for the quarter, compared to analysts’ expectations of $915.22 million. C.R. Bard had a return on equity of 48.43% and a net margin of 9.20%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period last year, the firm earned $2.27 earnings per share. Analysts predict that C.R. Bard Inc. will post $10.17 EPS for the current year.

A number of brokerages have weighed in on BCR. BMO Capital Markets restated a “hold” rating and issued a $240.00 target price on shares of C.R. Bard in a research note on Wednesday, July 27th. Morgan Stanley restated a “hold” rating and issued a $240.00 target price on shares of C.R. Bard in a research note on Thursday, July 28th. Deutsche Bank AG upped their target price on C.R. Bard from $234.00 to $240.00 and gave the stock a “hold” rating in a research note on Wednesday, July 27th. Barclays PLC upped their target price on C.R. Bard from $224.00 to $235.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 27th. Finally, Zacks Investment Research lowered C.R. Bard from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Thirteen research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. C.R. Bard currently has an average rating of “Hold” and a consensus price target of $233.00.

In other C.R. Bard news, Chairman Timothy M. Ring sold 92,293 shares of the firm’s stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $227.81, for a total transaction of $21,025,268.33. Following the sale, the chairman now directly owns 145,876 shares of the company’s stock, valued at $33,232,011.56. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Timothy M. Ring sold 110,000 shares of the firm’s stock in a transaction dated Monday, September 26th. The shares were sold at an average price of $228.96, for a total value of $25,185,600.00. Following the sale, the chairman now directly owns 96,030 shares in the company, valued at $21,987,028.80. The disclosure for this sale can be found here. Company insiders own 0.97% of the company’s stock.

C.R. Bard Company Profile

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

5 Day Chart for NYSE:BCR

Receive News & Stock Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related stocks with our FREE daily email newsletter.